Literature DB >> 27178183

Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer.

J H Marks1, G A Montenegro2,3, J F Salem2, M V Shields2, G J Marks2.   

Abstract

BACKGROUND: Natural orifice translumenal endoscopic surgery (NOTES) has always made more sense in the colorectal field where the target organ for entry houses the pathology. To address the question whether an adequate total mesorectal excision (TME) for rectal cancer can be performed from a transanal bottoms-up approach, we performed a case-matched study.
METHODS: Starting in 2009, transanal TME (taTME) surgery was selectively used for rectal cancer after neoadjuvant therapy and prospectively entered into a database. Between March 2012 and February 2014, 17 consecutive taTME rectal cancer patients were identified and case-matched to multiport laparoscopic TME (MP TME) based on age, body mass index, uT stage, radiation dose, level in the rectum, and procedure. Perioperative outcomes, morbidity, mortality, local recurrence, completeness of TME, and radial and distal margins were analyzed. Statistically significant differences were identified using Student's t test.
RESULTS: There were 12 transanal abdominal transanal (TATA)/5 abdominoperineal resection procedures in each group. Data regarding overall/taTME/MP TME are as follows: % positive-circumferential margin: 2.9/0/5.9 % (p = 0.32). Distal margin: 0/0/0 %. Complete or near-complete TME: 97.1/100/94.1 % (p = 0.32). Incomplete TME 2.9/0/5.9 % (p = 0.32). Local recurrence: 2.9/5.9/0 % (p = 0.32). There were no perioperative mortalities. Morbidity in each group: 26.4/23.5/29.4 % (p = 0.79). There were no differences in perioperative or postoperative outcomes except days to clear liquids (1/2 days, p = 0.03) and largest incision length (1.3/2.6 cm, p = 0.05).
CONCLUSIONS: We demonstrated no differences in perioperative/postoperative outcomes or pathologic TME outcomes of transanal or bottoms-up TME compared to standard laparoscopic TME. TaTME is a promising progressive approach to NOTES and deserves additional evaluation.

Entities:  

Keywords:  Laparoscopic surgery; NOTES; Rectal cancer; Sphincter-preserving surgery; TAMIS; TATA; TaTME

Mesh:

Year:  2016        PMID: 27178183     DOI: 10.1007/s10151-016-1482-y

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  35 in total

1.  Transanal minimally invasive surgery: a giant leap forward.

Authors:  Sam Atallah; Matthew Albert; Sergio Larach
Journal:  Surg Endosc       Date:  2010-02-21       Impact factor: 4.584

2.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

Authors:  Fatima A Haggar; Robin P Boushey
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 3.  Patterns of local recurrence in rectal cancer after a multidisciplinary approach.

Authors:  Jose M Enríquez-Navascués; Nerea Borda; Aintzane Lizerazu; Carlos Placer; Jose L Elosegui; Juan P Ciria; Adelaida Lacasta; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

4.  Endoscopic surgery in the rectum.

Authors:  G Buess; R Theiss; M Günther; F Hutterer; H Pichlmaier
Journal:  Endoscopy       Date:  1985-01       Impact factor: 10.093

Review 5.  Maximizing rectal cancer results: TEM and TATA techniques to expand sphincter preservation.

Authors:  John H Marks; Joseph L Frenkel; Anthony P D'Andrea; Chistopher E Greenleaf
Journal:  Surg Oncol Clin N Am       Date:  2011-07       Impact factor: 3.495

6.  Laparoscopic transanal abdominal transanal resection with sphincter preservation for rectal cancer in the distal 3 cm of the rectum after neoadjuvant therapy.

Authors:  J Marks; B Mizrahi; S Dalane; I Nweze; G Marks
Journal:  Surg Endosc       Date:  2010-04-23       Impact factor: 4.584

7.  Sphincter preservation for cancer of the distal rectum using high dose preoperative radiation.

Authors:  G Marks; M Mohiuddin; S D Goldstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-11       Impact factor: 7.038

8.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

9.  Transanal endoscopic microsurgery with entrance into the peritoneal cavity: is it safe?

Authors:  John H Marks; Joseph L Frenkel; Christopher E Greenleaf; Anthony P D'Andrea
Journal:  Dis Colon Rectum       Date:  2014-10       Impact factor: 4.585

10.  Variations in Laparoscopic Colectomy Utilization in the United States.

Authors:  Zhobin Moghadamyeghaneh; Joseph C Carmichael; Steven Mills; Alessio Pigazzi; Ninh T Nguyen; Michael J Stamos
Journal:  Dis Colon Rectum       Date:  2015-10       Impact factor: 4.585

View more
  25 in total

1.  Hartmann's reversal using a transanal and transabdominal approach.

Authors:  B Martin-Perez; G Diaz-DelGobbo; A Otero-Piñeiro; R Almenara; A M Lacy
Journal:  Tech Coloproctol       Date:  2016-12-03       Impact factor: 3.781

2.  Colonic conduit prolapse after transanal total mesorectal excision (taTME).

Authors:  A Balaphas; C Dumont; S Faes; C R Scarpa; B Roche; F Ris; N C Buchs; D Hahnloser
Journal:  Tech Coloproctol       Date:  2018-05-24       Impact factor: 3.781

3.  From TATA to NOTES, how taTME fits into the evolutionary surgical tree.

Authors:  J H Marks; J F Salem
Journal:  Tech Coloproctol       Date:  2016-07-05       Impact factor: 3.781

4.  Robotic transanal surgery (RTAS) with utilization of a next-generation single-port system: a cadaveric feasibility study.

Authors:  J Marks; S Ng; T Mak
Journal:  Tech Coloproctol       Date:  2017-07-14       Impact factor: 3.781

5.  Initial experience with taTME in patients undergoing laparoscopic restorative proctocolectomy for familial adenomatous polyposis.

Authors:  P C Ambe; H Zirngibl; G Möslein
Journal:  Tech Coloproctol       Date:  2017-11-22       Impact factor: 3.781

6.  Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis.

Authors:  Hong-Peng Jiang; Yan-Sen Li; Bo Wang; Chang Wang; Fan Liu; Zhan-Long Shen; Ying-Jiang Ye; Shan Wang
Journal:  Surg Endosc       Date:  2018-02-20       Impact factor: 4.584

Review 7.  Transanal Surgery: A History of taTME Ancestry.

Authors:  Kevin M Izquierdo; Jean F Salem; Esther Cha; Ece Unal; John H Marks
Journal:  Clin Colon Rectal Surg       Date:  2019-11-07

8.  Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.

Authors:  Shahin Hajibandeh; Shahab Hajibandeh; Mokhtar Eltair; Anil T George; Vijay Thumbe; Andrew W Torrance; Misra Budhoo; Howard Joy; Rajeev Peravali
Journal:  Int J Colorectal Dis       Date:  2020-03-02       Impact factor: 2.571

Review 9.  Transanal total mesorectal excision for rectal cancer: state of the art.

Authors:  David A Westwood; Tahleesa J Cuda; A E Ricardo Hamilton; David Clark; Andrew R L Stevenson
Journal:  Tech Coloproctol       Date:  2018-09-25       Impact factor: 3.781

10.  Transanal total mesorectal excision: 3-year oncological outcomes.

Authors:  S Ourô; D Albergaria; M P Ferreira; B Costeira; P Roquete; D Ferreira; R Maio
Journal:  Tech Coloproctol       Date:  2020-10-28       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.